Monday, 16 Sep 2019

You are here

Bariatric Surgery Thwarts Gout and Hyperuricemia

The rising incidence of gout has been directly linked to the obesity epidemic.  The influence of obesity on gout was further tested in a cohort study of obese patients undergoing bariatric surgery as part of the Swedish Obese Subjects (SOS) study.

This prospective intervention trial compared those receiving bariatric surgery (n= 1982) against obese controls (1999) receiving conventional treatment. None of the subjects had gout at baseline. The median followup for both groups was nearly 19 years. 

In the surgery group, 372 subjects underwent gastric banding, 1347 underwent vertical banded gastroplasty and 263 underwent gastric bypass.At the 2-year follow-up, BMI decreased by 23% in the surgery group, but no change in the control group.

Gout occurred more frequently in the control group (201) compared with the surgery group (138). The bariatric surgery had a significantly lower incidence of gout compared with usual care (adjusted HR 0.60, 95% CI 0.48 to 0.75, p<0.001). The number needed to be treated by bariatric surgery to prevent one gout event was 32

Figure 1

Similarly, the bariatric surgery cohort had a lower incidence of hyperuricaemia (adjusted HR 0.47, 95% CI 0.39 to 0.58, p<0.001) and the number of participants needed to be treated by bariatric surgery to prevent hyperuricaemia was 8 (95% CI 6 to 13).

The effect of bariatric surgery on gout incidence was not influenced by baseline risk factors, including body mass index.

The effectiveness of bariatric surgery in preventing gout and hyperuricaemia, underscores the value of weight reduction in gout prevention. 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Modifiable Risk Factors for Hyperuricemia

Choi and colleagues have shown that four modifiable risk factors (BMI, the DASH diet, alcohol use, and diuretic use) could individually account for a notable proportion of observed hyperuricemia. 

Researchers examine modifiable risk factors for hyperuricemia and how this could be prevented through risk factor modification in the general population.

Opioids Overused in Acute Gout

Opioids were commonly given to patients as a treatment for acute gout attacks, despite the availability of other effective and appropriate therapies, a retrospective study found.

Allopurinol Fails to Curtail Hypertension

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. A novel trial presented at EULAR 2019 last week assessed whether the use of urate-lowering therapy (ULT) would control hypertension in those at risk; however, results of this trial were largely negative.

Hypertension is one of the many comorbidities that plagues gout patients.

Allopurinol Fails to Curtail Hypertension

A novel trial presented at EULAR 2019 last week assessed whether the use of urate-lowering therapy (ULT) would control hypertension in those at risk; however, results of this trial were largely negative.

Hypertension is one of the many comorbidities that plagues gout patients.

Updated 2018 EULAR Recommendations for the Diagnosis of Gout

The first EULAR recommendations for the diagnosis of gout were published in 2006. A task force was formed and following a systematic review, they voted unanimously for changes in all items of the 2006 recommendations.